Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
60,57 USD | +6,08 % | +4,68 % | +52,34 % |
19/03 | Morphic Holding nombra a Simon Cooper director médico | MT |
15/03 | Las acciones de Keros Therapeutics suben tras la designación de vía rápida de la FDA para un posible fármaco contra la anemia | MT |
Resumen de negocios
Número de empleados: 136
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 01/12/15 |
Keith Regnante
DFI | Director of Finance/CFO | 54 | 01/02/20 |
Jennifer Lachey
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/07/16 |
Chief Operating Officer | 50 | 01/02/22 | |
Justin Frantz
IRC | Investor Relations Contact | - | - |
Robin Wagner
HRO | Human Resources Officer | - | 01/06/21 |
Esther Cho
LAW | General Counsel | - | 01/04/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 17/12/20 |
Carl Gordon
CHM | Chairman | 59 | 01/03/20 |
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 01/12/15 |
Tomer Kariv
BRD | Director/Board Member | 62 | 01/01/20 |
Ran Nussbaum
BRD | Director/Board Member | 51 | 01/04/16 |
Nima Farzan
BRD | Director/Board Member | 48 | 01/03/20 |
Julius Knowles
BRD | Director/Board Member | 61 | 01/04/16 |
Alpna Seth
BRD | Director/Board Member | 60 | 01/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 36 067 786 | 33 773 264 ( 93,64 %) | 0 | 93,64 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+52,34 % | 2184,63 M | |
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+38,61 % | 12,63 mil M | |
+313,59 % | 8487,34 M |
- Bolsa de valores
- Acciones
- Acción KROS
- Empresa Keros Therapeutics, Inc.